TRexBio is a biotechnology company developing novel therapies for inflammatory diseases using their Deep Biology platform to focus on immune homeostasis.

Cantai Therapeutics develops cytokine-targeting bispecific antibodies for autoimmune and inflammatory disorders.

Jana Care, Inc. develops self-administered blood tests for chronic kidney and heart disease management, with a focus on at-home testing and remote clinician review.

Star Therapeutics is a biotechnology company that develops first-in-class antibody therapies, primarily for hematology and immunology, and also generates additional biotech companies focused on discovering and advancing novel antibody therapies.